Product Code: GVR-4-68040-552-0
U.S. Surgical Dressings Market Trends:
The U.S. surgical dressings market size was estimated at USD 1.52 billion in 2024 and is expected to grow at a CAGR of 4.09% from 2025 to 2030. The rising number of surgical procedures and the growing prevalence of chronic wounds, such as diabetic foot ulcers & pressure ulcers, are some of the factors driving the market growth. According to data published by the Agency for Healthcare Research and Quality in February 2024, approximately 2.5 million people develop pressure ulcers in the U.S. Furthermore, innovations like smart dressings and 3D printing are anticipated to boost the effectiveness of surgical dressings.
Moreover, the increasing prevalence of organ transplant surgeries significantly drives the surgical dressings market due to the heightened demand for specialized wound care products post-surgery. For instance, as per a report by the Organ Procurement and Transplantation Network, in January 2025, around 48,149 transplants were performed in the U.S., marking a 3.3 percent increase compared to the total in 2023 and a 23.3 percent rise over the past five years in the U.S. As organ transplant surgeries rise, the need for advanced wound care solutions such as antibacterial dressings, hydrocolloids, hydrogels, and film dressings is anticipated to increase. These dressings offer optimal moisture balance, enhance healing, and provide antimicrobial properties, essential for patients recovering from invasive surgeries like organ transplants.
The growing prevalence of chronic and acute wounds, including diabetic ulcers, pressure ulcers, burns, and venous leg ulcers, is the key factor driving the growth of the U.S. surgical dressings market. This rise is mainly due to the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. According to CDC data published in December 2023, around 96 million adults (38% of U.S. adults) have prediabetes, with over 80% unaware of their condition. Diabetic foot ulcers are a common complication of severe diabetes, while pressure ulcers often occur in cancer patients.
Therefore, the high burden of these chronic diseases is expected to boost the demand for surgical dressings to manage wounds arising from surgical procedures related to these conditions.
In addition, there has been a significant rise in cosmetic surgical procedures. Data released by Discovery ABA in February 2024 reveals that roughly 26.2 million surgical and minimally invasive reconstructive and cosmetic procedures were performed in 2022 in the U.S., reflecting a significant 19% increase in cosmetic surgeries since 2019. Surgical dressings are utilized during aesthetic and plastic surgeries. Thus, the growing number of cosmetic surgical procedures is projected to further enhance market growth over the forecast period.
U.S. Surgical Dressings Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. surgical dressings market report based on product, application, and end use:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Primary
- Foam Dressing
- Alginate Dressing
- Soft Silicone Dressing
- Composite Dressing
- Hydrogel Dressing
- Hydrocolloid Dressing
- Film Dressing
- Secondary
- Absorbents
- Bandages
- Muslin Bandage Rolls
- Elastic Bandage Rolls
- Triangular Bandages
- Orthopedic Bandages
- Elastic Plaster Bandages
- Other Bandages
- Adhesive Tapes
- Protectives
- Others
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Diabetes related surgeries
- Cardiovascular related surgeries
- Ulcers
- Burns
- Transplant Sites
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Ambulatory Surgery Centers
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Surgical Dressings Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing prevalence of wounds
- 3.2.1.2. Rising number of surgical procedures
- 3.2.1.3. Increasing prevalence of organ transplant surgeries
- 3.2.1.4. Rising burden of chronic diseases
- 3.2.2. Market Restraint Analysis
- 3.2.3. Market Opportunities Analysis
- 3.2.3.1. Growing number of clinical trials
- 3.2.3.2. Rising incidence of sports injuries and road accidents
- 3.2.3.3. Increasing development of wound centers and healthcare facilities
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Complications and risks associated with surgical dressings
- 3.3. U.S. Surgical Dressings Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. U.S. Surgical Dressings Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Surgical Dressings Market Movement Analysis
- 4.3. U.S. Surgical Dressings Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Primary
- 4.4.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Foam Dressing
- 4.4.2.1. Foam Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Alginate Dressing
- 4.4.3.1. Alginate Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Soft Silicone Dressing
- 4.4.4.1. Soft Silicone Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Composite Dressing
- 4.4.5.1. Composite Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.6. Hydrocolloid Dressing
- 4.4.6.1. Hydrocolloid Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.7. Film Dressing
- 4.4.7.1. Film Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.8. Hydrogel Dressing
- 4.4.8.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Secondary
- 4.5.1. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Absorbents
- 4.5.2.1. Absorbents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Bandages
- 4.5.3.1. Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.2. Muslin Bandage Rolls
- 4.5.3.2.1. Muslin Bandage Rolls Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.3. Elastic Bandage Rolls
- 4.5.3.3.1. Elastic Bandage Rolls Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.4. Triangular Bandages
- 4.5.3.4.1. Triangular Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.5. Orthopedic Bandages
- 4.5.3.5.1. Orthopedic Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.6. Elastic Plaster Bandages
- 4.5.3.6.1. Elastic Plaster Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3.7. Other Bandages
- 4.5.3.7.1. Other Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Adhesive Tapes
- 4.5.4.1. Adhesive Tapes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.5. Protectives
- 4.5.5.1. Protectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.6. Others
- 4.5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Surgical Dressings Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Surgical Dressings Market Movement Analysis
- 5.3. U.S. Surgical Dressings Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Diabetes Related Surgeries
- 5.4.1. Diabetes Related Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Cardiovascular Related Surgeries
- 5.5.1. Cardiovascular Related Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Ulcers
- 5.6.1. Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Burns
- 5.7.1. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Transplant Sites
- 5.8.1. Transplant Sites Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Surgical Dressings Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Surgical Dressings Market Movement Analysis
- 6.3. U.S. Surgical Dressings Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Specialty Clinics
- 6.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Ambulatory Surgery Centers
- 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Home Healthcare
- 6.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Market Participant Categorization
- 7.2. Key Company Profiles
- 7.2.1. 3M
- 7.2.1.1. Company Overview
- 7.2.1.2. Financial Performance
- 7.2.1.3. Product Benchmarking
- 7.2.1.4. Strategic Initiatives
- 7.2.2. Smith+Nephew
- 7.2.2.1. Company Overview
- 7.2.2.2. Financial Performance
- 7.2.2.3. Product Benchmarking
- 7.2.2.4. Strategic Initiatives
- 7.2.3. Molnlycke Health Care AB
- 7.2.3.1. Company Overview
- 7.2.3.2. Financial Performance
- 7.2.3.3. Product Benchmarking
- 7.2.3.4. Strategic Initiatives
- 7.2.4. Convatec Group PLC
- 7.2.4.1. Company Overview
- 7.2.4.2. Financial Performance
- 7.2.4.3. Product Benchmarking
- 7.2.4.4. Strategic Initiatives
- 7.2.5. Essity
- 7.2.5.1. Company Overview
- 7.2.5.2. Financial Performance
- 7.2.5.3. Product Benchmarking
- 7.2.5.4. Strategic Initiatives
- 7.2.6. DeRoyal Industries, Inc.
- 7.2.6.1. Company Overview
- 7.2.6.2. Financial Performance
- 7.2.6.3. Product Benchmarking
- 7.2.6.4. Strategic Initiatives
- 7.2.7. Coloplast Corp
- 7.2.7.1. Company Overview
- 7.2.7.2. Financial Performance
- 7.2.7.3. Product Benchmarking
- 7.2.7.4. Strategic Initiatives
- 7.2.8. INTEGRA LIFESCIENCES
- 7.2.8.1. Company Overview
- 7.2.8.2. Financial Performance
- 7.2.8.3. Product Benchmarking
- 7.2.8.4. Strategic Initiatives
- 7.2.9. Medline Industries, LP.
- 7.2.9.1. Company Overview
- 7.2.9.2. Financial Performance
- 7.2.9.3. Product Benchmarking
- 7.2.9.4. Strategic Initiatives
- 7.2.10. Cardinal Health
- 7.2.10.1. Company Overview
- 7.2.10.2. Financial Performance
- 7.2.10.3. Product Benchmarking
- 7.2.10.4. Strategic Initiatives
- 7.2.11. MIMEDX Group, Inc.
- 7.2.11.1. Company Overview
- 7.2.11.2. Financial Performance
- 7.2.11.3. Product Benchmarking
- 7.2.11.4. Strategic Initiatives
- 7.2.12. Urgo Medical North America
- 7.2.12.1. Company Overview
- 7.2.12.2. Financial Performance
- 7.2.12.3. Product Benchmarking
- 7.2.12.4. Strategic Initiatives